KENYA BIOVAX INSTITUTE LIMITED TENDER MARCH 2026
REQUEST FOR EXPRESSIONS OF INTEREST
(CONSULTING SERVICES – FIRMS SELECTION)
| Country: | Republic of Kenya |
| Name of Project: | HEALTH EMERGENCY PREPAREDNESS RESPONSE AND RESILIENCE PROJECT |
| Credit No: | 7405-KE |
| Project ID: | P180127 |
| Reference No. | KE-KBI-537982-CS-QCBS |
| ASSIGNMENT TITLE: | CONSULTING SERVICES FOR PREPARATION OF PRELIMINARY ENGINEERING DESIGNS, EMPLOYER REQUIREMENTS AND CONSTRUCTION SUPERVISION, AND GOOD MANUFACTURING PRACTICE COMPLIANCE CERTIFICATION FOR ESTABLISHMENT OF A HUMAN VACCINES AND BIOLOGICALS FILL–FINISH MANUFACTURING FACILITY |
- The Government of Kenya (GoK) has received financing from the World Bank toward the cost of the Health Emergency Preparedness
Response and Resilience (HEPRR) Project and intends to apply part of the proceeds for consulting services. - The consulting services (“the Services”) includes consulting services for Preparation of Preliminary Engineering Designs, Employer
Requirements and Construction Supervision, and Good Manufacturing Practice Compliance Certification for Establishment
of a Human Vaccines and Biologicals Fill–Finish Manufacturing Facility. The duration of the assignment will be Thirty-Six (36)
Months from the contract commencement date. - The detailed Terms of Reference (ToR) for the assignment can be found at the following Kenya Biovax Institute Limited’s website:
www.biovax.go.ke. - The Kenya Biovax Institute Limited now invites eligible consulting firms (“Consultants”) to indicate their interest in providing
the Services. Interested Consultants should provide information demonstrating that they have the required qualifications and
relevant experience to perform the Services. The shortlisting criteria are:
4.1 Core business and years in business
The consulting firm shall be legally registered/incorporated as a consulting entity and shall have its core business providing
expertise in project management, preparation of preliminary designs, employers requirements, construction supervision,
GMP compliance certification support and technology transfer projects oversight for pharmaceutical/biopharmaceutical/
human vaccines and biologicals manufacturing companies, for a minimum period of ten (10) years.
4.2 Relevant experience:
The consulting firm shall demonstrate having successfully executed, completed and supported GMP compliance certification
of at least one (1) assignment of similar nature, scope, scale, and complexity within the last ten (10) years.
Details of similar assignments shall be provided in the expression of interest, including the Client’s name and address, scope
of services, contract value, period of execution, and the consultant’s role.
4.3 Technical and managerial capability of the firm:
The consulting firm shall demonstrate adequate technical capacity and managerial capability to undertake this assignment,
supported by submitted company profiles, organizational structures, and availability of suitably qualified experts.
Key Experts will not be evaluated at the shortlisting stage. - The attention of interested Consultants is drawn to Section III, paragraphs, 3.14, 3.16, and 3.17 of the World Bank’s “Procurement
Regulations for IPF Borrowers” First Published July 2016 and Revised Fourth Edition, November 2020 (“Procurement
Regulations”), setting forth the World Bank’s policy on conflict of interest. - Consultants may associate with other firms to enhance their qualifications but should indicate clearly whether the association is
in the form of a joint venture and/or a sub-consultancy. In the case of a joint venture, all the partners in the joint venture shall
be jointly and severally liable for the entire contract, if selected. - A Consultant will be selected in accordance with the Quality Cost Based Selection (QCBS) method set out in the World Bank
Procurement Regulations. - Further information can be obtained at the address below during office hours 0900 to 1700 hours East African Time (EAT) from
Monday to Friday excluding lunch hour (1300 to 1400hours (EAT) and public holidays. - Expressions of Interest must be delivered in a written form to the address below In person or by mail or email and be clearly
marked “Expression of Interest Preparation of Preliminary Engineering Designs, Employer Requirements and Construction
Supervision, and Good Manufacturing Practice Compliance Certification for Establishment of a Human Vaccines
and Biologicals Fill–Finish Manufacturing Facility” by 31st March 2026 at 1000 hours East African Time.
EOI submissions delivered by email should strictly be sent to: HEPRRProcurement@biovax.go.ke
Address:
Become Member To see All details. Join us Or Login
